Publication:

Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostars

Date

2017
Journal article
Simple item page Full metadata Statistics
 
dc.contributor.authorD'Hollander, Antoine
dc.contributor.authorJans, Hilde
dc.contributor.authorVande Velde, Greetje
dc.contributor.authorVerstraete, Charlotte
dc.contributor.authorMassa, Sam
dc.contributor.authorStakenborg, Tim
dc.contributor.authorMuyldermans, Serge
dc.contributor.authorLagae, Liesbet
dc.contributor.authorHimmelreich, Uwe
dc.contributor.imecauthorD'Hollander, Antoine
dc.contributor.imecauthorJans, Hilde
dc.contributor.imecauthorStakenborg, Tim
dc.contributor.imecauthorLagae, Liesbet
dc.contributor.orcidimecStakenborg, Tim::0000-0001-9878-9078
dc.date.accessioned2021-10-24T04:17:37Z
dc.date.available2021-10-24T04:17:37Z
dc.date.issued2017
dc.identifier.issn0142-9612
dc.identifier.urihttps://imec-publications.be/handle/20.500.12860/28243
dc.identifier.urlhttp://dx.doi.org/10.1016/j.biomaterials.2017.01.007
dc.source.beginpage15
dc.source.endpage23
dc.source.journalBiomaterials
dc.source.volume123
dc.title

Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostars

dc.typeJournal article
dspace.entity.typePublication
Files
Publication available in collections:
Articles